Department of Otolaryngology- Head and Neck, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Front Immunol. 2023 Jan 27;14:1096220. doi: 10.3389/fimmu.2023.1096220. eCollection 2023.
The maturity and spatial distribution of tertiary lymphoid structures (TLSs) vary dynamically within and between cancers, leading to a controversial role in cancer. We aimed to develop a simple morphology-based approach to identify the maturity of TLSs in laryngeal squamous cell carcinoma and examine their clinically relevant functional role.
TLSs were identified based on morphological features hematoxylin and eosin (H&E) staining, and the accuracy was verified by multi-immunohistochemical analysis. The density, maturity, spatial distribution and prognostic value of TLSs were separately analyzed in two human laryngeal cancer cohorts. The TLS profile was linked to RNA-seq data from the TCGA database to perform bioinformatics analysis.
TLSs can be classified as early TLSs (E-TLSs), primary follicle-like TLSs (PFL-TLSs) and secondary follicle-like TLSs (SFL-TLSs). The three types of TLSs showed higher infiltration in the extratumoral region. XCL2 is a vital chemokine in the maturation and infiltration of TLSs. FL-TLS was an independent positive prognostic indicator in laryngeal cancer. The FL-TLS group had more abundant immune cell infiltration and a better response to immunotherapies than the non-FL-TLS group. Functional analysis showed that the non-FL-TLS group was enriched in tumor invasion, metastasis and immunosuppression pathways.
The maturity of TLSs can be accurately classified by H&E staining. FL-TLS is a potential mediator of antitumor immunity in human laryngeal cancer.
三级淋巴结构 (TLSs) 的成熟度和空间分布在癌症内部和之间动态变化,导致其在癌症中的作用存在争议。我们旨在开发一种基于形态学的简单方法来识别喉鳞状细胞癌中 TLSs 的成熟度,并研究其与临床相关的功能作用。
基于形态学特征(苏木精和伊红 [H&E] 染色)识别 TLSs,并通过多免疫组织化学分析验证准确性。分别在两个人类喉癌队列中分析 TLSs 的密度、成熟度、空间分布和预后价值。将 TLS 谱与 TCGA 数据库中的 RNA-seq 数据相关联,以进行生物信息学分析。
TLSs 可分为早期 TLSs (E-TLSs)、初级滤泡样 TLSs (PFL-TLSs) 和次级滤泡样 TLSs (SFL-TLSs)。这三种类型的 TLSs 在肿瘤外区域的浸润程度更高。XCL2 是 TLS 成熟和浸润的重要趋化因子。FL-TLS 是喉癌的独立阳性预后指标。FL-TLS 组的免疫细胞浸润更丰富,对免疫治疗的反应更好,而非 FL-TLS 组则相反。功能分析显示,非 FL-TLS 组在肿瘤侵袭、转移和免疫抑制途径中富集。
H&E 染色可准确分类 TLSs 的成熟度。FL-TLS 可能是人类喉癌抗肿瘤免疫的潜在介质。